This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Vitamin Science, Inc.
Ophthalmologist Dr. Paul Krawitz, President and Founder of Vitamin Science Inc., has introduced the first-ever nutritional supplement calibrated to optimize vision for peak athletic performance and certified pure by the Banned Substances Control Group (BSCG) Program.
Huntington, New York (PRWEB) November 14, 2012
Sports blooper reels featuring dropped balls, whiffs, fumbles and mis-hits are about to become a thing of the past. VisiVite, an industry-leading brand of science-backed eye vitamins, has announced its release of R.B.I. Vision Performance™ – the World’s First Vision Accelerator. Billed as “The New Eye Black,” R.B.I. is the first-ever nutritional supplement to support athletic performance by optimizing multiple aspects of vision.
Athletes across all sports deal with visual contrast, glare and acuity issues that can hold back their game. R.B.I. Vision Performance is a doctor-formulated, patent-pending blend of ingredients backed by abundant scientific evidence, including astaxanthin, saffron, lutein, zeaxanthin, and black currant extract (CG3). Together, these cutting-edge compounds work as a Retinal Baselayer Infusion of nutrition that optimizes critical high-speed eyesight functions that are closely tied to peak athletic performance:
“We are excited to bring a safe, natural and legal performance enhancer to edge-driven athletes with R.B.I. Vision Performance,” commented Dr. Paul Krawitz, an internationally-acclaimed Ophthalmologist, C.E.O. of Vitamin Science, Inc., and creator of R.B.I. “With evidence-backed ingredients presented in carefully balanced ratios, we’ve created a game-changer for athletes everywhere… as well as for anyone seeking to gain the vision of an athlete.”
R.B.I. Vision Performance is certified pure by the Banned Substances Control Group (BSCG) Program. An anti-doping leader, BSCG provides pre-market, third-party verification that supplements are free of anabolic agents, stimulants, beta-2-agonists, diuretics, synthetic drugs, masking agents and any other contaminants.
“Pro, amateur, collegiate or casual -- whatever your athletic level, you deserve unadulterated sports nutrition,” commented Krawitz. “That's why we go to such great lengths to guarantee that R.B.I. Vision Performance is safe, clean and banned substance-free.”
Research reveals that nutrients in R.B.I. Vision Performance restore peak macular pigment, helping to maintain sharp vision, hand-eye coordination and reaction time. Research further suggests that R.B.I.’s nutrients help to reduce eye fatigue and eyestrain, sharpen depth perception, boost focus speed, energize eyes and accelerate electrical transmission speed in the retina.
All of R.B.I.’s nutritional benefits culminate to support an athletic edge: Recognizing a curveball sooner, reacting to a powerful serve faster, achieving a cleaner strike on your golf drives, or even locating golf balls in the rough more easily. Hunters, sharpshooters, gamers, car and truck drivers, photographers and sports spectators may also benefit by gaining the vision of an athlete with R.B.I. Vision Performance.
Vitamin Science, Inc., creates pure, natural, evidence-backed VisiVite® supplements for optimizing eye health. R.B.I. Vision Performance is the latest addition to VisiVite’s product lineup, which also includes the i-Defense line of targeted macular health support formulas, Premier Ocular Nutrition No. 2 and other advanced macular formulas, Balanced Ocular Support hereditary eye health formula, and more. For additional information on R.B.I. Vision Performance and other VisiVite formulas, call (800) 427-7660 Ext 2 or visit http://www.visivite.com. For more news, updates, and in depth information on R.B.I. Vision Performance, visit http://www.rbivitamins.com.
Vitamin Science, Inc.
PO Box 1128
Huntington, New York 11743, USA
Toll-Free within USA: 1-800-427-7660, Ext. 2
Email: media @ rbivitamins.com
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10125180.htm